BIOCODEX
🏢 View company profile →15Patents
14Active
15Granted
45Portfolio score
Filing activity: Dec 23, 2004 → Nov 16, 2018 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8598221B2 | Synergistic combination of analgesic compounds | Human Necessities | 6 | Active |
| US8575211B2 | Synergistic combination of analgesic compounds | Human Necessities | 5 | Active |
| US8338410B2 | Neuroprotective compounds and pharmaceutical compositions comprising them | Human Necessities | 3 | Active |
| US7799328B2 | Method for treating weight loss in patients suffering from inflammatory bowel diseases | Human Necessities | 3 | Expired |
| US9872858B2 | Treatment of degenerations and light-induced damage to the retina | Human Necessities | 2 | Active |
| US11872257B2 | Saccharomyces boulardii for the treatment of mood disorders | Human Necessities | 0 | Active |
| US10696647B2 | Pharmacological treatment of obsessive-compulsive disorder | Human Necessities | 0 | Active |
| US8093381B2 | Method of synthesis of fluoroquinolones | Chemistry; Metallurgy | 0 | Active |
| US7569565B2 | Pharmaceutical composition for the prevention or treatment of cerebral oedemas | Emerging Cross-Sectional Technologies | 0 | Active |
| US11141440B2 | Pharmaceutical oral formulation comprising bacteria | Emerging Cross-Sectional Technologies | 0 | Active |
| US10525092B2 | Compositions and methods for preventing infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US10675266B2 | Compounds and methods for treating autism spectrum disorders | Chemistry; Metallurgy | 0 | Active |
| US8927600B2 | Compound for use in the treatment of peripheral neuropathies | Human Necessities | 0 | Active |
| US8420644B2 | Pharmaceutical composition intended for the prevention or for the treatment of cerebral oedemas | Human Necessities | 0 | Active |
| US7750169B2 | Process for the preparation of stiripentol particles having a defined particle size distribution | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.